USPTO serial 99530956
ENDOROSE
Status 641Office Action
- Filing date
- Dec 4, 2025
- Status date
- Aug 29, 2026
- Registration date
- —
- Examiner
- REID, CAILE MAUREEN
Need help with ENDOROSE?
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Deadline: November 29, 2026
Office Action issues
The examiner has identified that you need to address federal law compliance for your product ingredients, provide additional information about your goods, and clarify your product descriptions.
Owner
Kearia T Schroeder
Los Angeles, CA, US
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Transdermal patches featuring Magnesium,Arnica, Turmeric (Curcumin),Ginger Extract,CBD (optional variant) Chamomile,Lavender,Menthol | ACTIVE | — |
Prosecution history
| Date | Code | Event |
|---|---|---|
| Aug 29, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Aug 29, 2026 | GNRT | NON-FINAL ACTION E-MAILED |
| Aug 29, 2026 | CNRT | NON-FINAL ACTION WRITTEN |
| Aug 25, 2026 | DOCK | ASSIGNED TO EXAMINER |
| Apr 6, 2026 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Apr 6, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Dec 4, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED |
| Dec 4, 2025 | NWAP | NEW APPLICATION ENTERED |